Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Melo Technology (Shanghai) Co., Ltd. is a biotechnology company specializing in high-throughput single-cell sequencing and spatial multi-omics technologies. The company offers a suite of services and products designed to map the molecular landscape of tissues at single-cell resolution, providing critical insights into cellular heterogeneity and spatial architecture. Their core offerings include spatial transcriptomics, single-cell RNA sequencing, and advanced bioinformatics solutions tailored for drug discovery and clinical research. By integrating cutting-edge molecular biology with computational analysis, Melo Technology supports researchers in fields such as oncology, immunology, and neuroscience to identify new biomarkers and therapeutic targets. The company is dedicated to advancing precision medicine through innovative molecular profiling tools that resolve complex biological systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 魅罗科技.